Catalent will provide vial filling and packaging capacity, as well as additional staffing required for 24x7 manufacturing operations.
Jun 26, 2020
By : Team ABLE
FICCI also released a whitepaper on ‘Economical, Accurate and Scalable COVID-19 Testing Solutions’ during the webinar.
Sanofi will receive exclusive worldwide rights to develop, manufacture and commercialize infectious disease vaccines using Translate Bio technology
Jun 25, 2020
Genexine received approval for clinical phase 1/2a of GX-19, a DNA vaccine against COVID-19, by the country’s Ministry of Food and Drug Safety.
JNCASR has embarked upon a campaign by establishing a state-of-the-art diagnostic training facility to train personnel in real-time PCR for COVID-19.
June 22-25 | San Diego, USA
Applications Open
